Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis

MicroRNA-365 regulates NKX2-1, a key mediator of lung cancer

(2013) Sung-Min Kang et al.   CANCER LETTERS

Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors

(2013) Andliena Tahiri et al.   CARCINOGENESIS

Serum Circulating microRNA Profiling for Identification of Potential Breast Cancer Biomarkers

(2013) Fermín Mar-Aguilar et al.   DISEASE MARKERS

Technologies for detection of circulating tumor cells: facts and vision

(2013) Catherine Alix-Panabières et al.   LAB ON A CHIP

Plasma MicroRNA Panel for Minimally Invasive Detection of Breast Cancer

(2013) Katarina Cuk et al.   PLoS One

Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures

(2013) Dharanija Madhavan et al.   Frontiers in Genetics

Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer

(2012) D. Madhavan et al.   CLINICAL CANCER RESEARCH

Circulating microRNAs in plasma as early detection markers for breast cancer

(2012) Katarina Cuk et al.   INTERNATIONAL JOURNAL OF CANCER

Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer

(2012) A Ward et al.   ONCOGENE

Comparing the MicroRNA Spectrum between Serum and Plasma

(2012) Kai Wang et al.   PLoS One

Distinct AGO1 and AGO2 associated miRNA profiles in human cells and blood plasma

(2012) Andrey Turchinovich et al.   RNA Biology

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

microRNA-365, down-regulated in colon cancer, inhibits cell cycle progression and promotes apoptosis of colon cancer cells by probably targeting Cyclin D1 and Bcl-2

(2011) Jing Nie et al.   CARCINOGENESIS

MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines

(2011) Giuditta Viticchiè et al.   CELL CYCLE

Emerging molecular biomarkers—blood-based strategies to detect and monitor cancer

(2011) Samir M. Hanash et al.   Nature Reviews Clinical Oncology

Characterization of extracellular circulating microRNA

(2011) Andrey Turchinovich et al.   NUCLEIC ACIDS RESEARCH

A Pilot Study of Circulating miRNAs as Potential Biomarkers of Early Stage Breast Cancer

(2010) Hua Zhao et al.   PLoS One

Locally recurrent or metastatic breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

(2009) F. Cardoso et al.   ANNALS OF ONCOLOGY

HTqPCR: high-throughput analysis and visualization of quantitative real-time PCR data in R

(2009) H. Dvinge et al.   BIOINFORMATICS

miR-200 Enhances Mouse Breast Cancer Cell Colonization to Form Distant Metastases

(2009) Derek M. Dykxhoorn et al.   PLoS One

Prognostic factors in 1038 women with metastatic breast cancer

(2008) R. Largillier et al.   ANNALS OF ONCOLOGY

Detection and Characterization of Placental MicroRNAs in Maternal Plasma

(2008) S. S.C. Chim et al.   CLINICAL CHEMISTRY

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

(2008) Philip A. Gregory et al.   NATURE CELL BIOLOGY

MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis

(2008) L.-X. Yan et al.   RNA